Congenital Cytomegalovirus-Related Hearing Loss

Nicoleta Gana1, Iulia Huluță1,2, Mihai-Ștefan Cătănescu1

  • 1Filantropia Clinical Hospital, 011171 Bucharest, Romania.

Audiology Research
|June 26, 2024
PubMed

Insights

Congenital hearing loss affects millions of newborns globally. This review focuses on diagnosing and managing hearing loss caused by congenital cytomegalovirus (cCMV), highlighting early detection and interdisciplinary care.

Area of Science:

  • Pediatrics
  • Genetics
  • Infectious Diseases

Background:

  • Congenital hearing loss (CHL) is a major global health issue affecting newborns and infants.
  • CHL can result from genetic factors, prenatal exposures, infections, or birth complications, impacting speech, language, and cognitive development.
  • Early detection and intervention are vital for mitigating long-term effects on education and social integration.

Purpose of the Study:

  • To review diagnostic approaches for congenital cytomegalovirus (cCMV)-related hearing loss.
  • To explore management strategies for cCMV-induced hearing loss.
  • To emphasize interdisciplinary care and the role of technology in improving outcomes for affected infants.

Main Methods:

  • Literature review of diagnostic methods for cCMV.
  • Analysis of current management strategies for CHL due to cCMV.
  • Discussion of technological advancements in hearing loss intervention.

Main Results:

  • Early identification of cCMV is critical for timely intervention.
  • A range of interventions, including hearing aids and cochlear implants, can significantly improve outcomes.
  • Interdisciplinary care coordination is essential for comprehensive management.

Conclusions:

  • Congenital cytomegalovirus is a significant preventable cause of congenital hearing loss.
  • Prompt diagnosis and appropriate management, including audiological monitoring and rehabilitation, are crucial.
  • Technological innovations offer promising avenues for enhancing the quality of life for children with cCMV-related hearing loss.